Gene Therapy Market Research Reports & Industry Analysis
Gene therapy is an innovative field with the potential to develop new, personalized medical treatments for previously challenging conditions. At MarketResearch.com, we are committed to providing you with comprehensive gene therapy industry reports that shed light on this fast-growing market.
Understanding the Gene Therapy Market
- Our gene therapy market research reports provide valuable insights into this dynamic field to help you understand the key factors at play, prepare for challenges, and leverage technological advancements.
- Our research collection covers various markets—such as gene therapy, precision medicine, delivery devices, and manufacturing services—with data on market size and growth projections.
- In addition, we also delve into market segmentation, key developments, industry trends, and company profiling to give you the full picture of the market.
Helping You Stay Ahead
Whether you're an experienced industry professional, a consultant, or a busy executive, our gene therapy market research reports provide valuable insights. These reports are based on reliable data and expert analysis to help you make informed business decisions. With MarketResearch.com, you can stay ahead of the competition and take advantage of emerging market opportunities.
Gene Therapy Industry Research & Market Reports
-
2024 Global Cell And Gene Therapy Manufacturing Services Market Industry (2030 Outlook)
... 46 countries (Wharry Sharpe Research) The Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 ... Read More
-
Global Bone Morphogenetic Protein (BMP) 2 Market Research Report 2024
... a CAGR of 8.91% during 2024-2030. North American market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ 432.24 million in 2023 to reach $ 653 million by 2030, at a CAGR ... Read More
-
Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
... in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body's immune system. Recent years have seen an increase in new therapies and the pipeline indicates ... Read More
-
AAV vectors in gene therapy – Pipeline Insight, 2024
... therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the ... Read More
-
Cell and Gene Therapies in Ophthalmology
... pigmentosa (retinitis) and Leber congenital amaurosis (LCA), is marketed globally, and is the only gene therapy on the market within the ophthalmology space. All other marketed CGTs are cell therapies. Holostem Terapie Avanzate’s Holoclar is ... Read More
-
Cell Culture Market, By Product (Consumables, Instruments), By Application (Biopharmaceutical Production, Tissue Culture & Engineering, Toxicity Testing, Drug Development, Cell & Gene Therapy, and Others), By End User (Biopharmaceutical Companies, Hospitals & Diagnostic Laboratories, CMO & CRO, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... & CRO, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) The cell culture market has seen significant growth in the last few decades driven by advancements in biomedical ... Read More
-
Spinal Muscular Atrophy Market, by Type (Type I, Type II, Type III, and Type IV), by Treatment (Gene Therapy and Disease-modifying drugs), by Age Group (Infant and Adult), by Route of Administration (Oral and Injectables), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031 Spinal ... Read More
-
Global Cell and Gene Therapy Market
... type, product, application, and region. BCC determines the current market status in each segment, examines its impact on future needs, and presents growth forecasts over the next five years. The report provides a detailed analysis ... Read More
-
Cell and Gene Therapies in CNS Disorders
... therapies, and three conditionally approved cell therapies. Novartis’s Zolgensma (onasemnogene abeparvovec) for the treatment of spinal muscular atrophy (SMA) was the first CGT asset to receive traditional approval in the CNS market in 2019. Over ... Read More
-
2024 Global: Cancer Gene Therapy Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
Microcarrier Market Analysis and Forecast to 2033: By Product (Consumables and Equipment), Application (Biopharmaceutical Production, Cell & Gene Therapy, Tissue Engineering, and Others), End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Others), and Region
... microcarrier is a small particle, typically ranging in size from 0.1 to 10 micrometers, that can be used to culture cells in suspension. Microcarriers are usually made of polystyrene, glass, or other biocompatible materials, and ... Read More
-
2024 Global: Cell And Gene Therapy Clinical Trials - Innovative Markets Forecast (2030) report
... and regional data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions ... Read More
-
Biological Safety Testing Market Size, Trends, Analysis, and Outlook By Product & Services (Consumables, Instrument, Services), By Application (Vaccine Development and Manufacturing, Monoclonal Antibodies Development and Manufacturing, Cellular & Gene Therapy Products Development and Manufacturing, Blood and Blood Products Development and Manufacturing, Others), By Test (Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-cell Proteins & DNA Detection Tests, Virus safety Test, Others), by Region, Country, Segment, and Companies, 2024-2030
... Blood and Blood Products Development and Manufacturing, Others), By Test (Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-cell Proteins & DNA Detection Tests, Virus safety Test, Others), by Region, Country, Segment, and Companies, ... Read More
-
Cancer Biologics Market Size, Trends, Analysis, and Outlook By Product (Monoclonal antibodies, Cell and gene therapy, Vaccines, Others), By Route of Administration (Injectable, Oral), by Region, Country, Segment, and Companies, 2024-2030
... market size is poised to register 9.88% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cancer Biologics market By Product (Monoclonal ... Read More
-
Cell and Gene Therapy Market Size, Trends, Analysis, and Outlook By Type (Cell Therapy, Gene Therapy), By Gene Type, Gene silencing, Cell replacement, Gene augmentation, Others), By Cell Type (T-Cells, Stem Cells, Other), By Application (Oncology, Dermatology, Musculoskeletal, Genetic Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030
... (Oncology, Dermatology, Musculoskeletal, Genetic Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Cell and Gene Therapy market size is poised to register 20.38% growth (CAGR) from 2024 to 2030, presenting significant growth ... Read More
-
Primary Immunodeficiency Therapeutics Market Size, Trends, Analysis, and Outlook By Disease (Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders, Others), By Product (Immunoglobulin Replacement Therapy, Stem Cell/Bone Marrow Transplantation, Antibiotic Therapy, Gene Therapy, Others), by Region, Country, Segment, and Companies, 2024-2030
... Country, Segment, and Companies, 2024-2030 The global Primary Immunodeficiency Therapeutics market size is poised to register 7.55% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry ... Read More
-
Solid Tumors Drugs Market Size, Trends, Analysis, and Outlook By Type (Small Molecules, Biologics (Enzymes, Blood and Blood Components, Gene Therapy, Recombinant Proteins, Somatic Cells, Tissues, Vaccines)), By Application (Oncology, Radiology, Neurology, Others), by Region, Country, Segment, and Companies, 2024-2030
... Country, Segment, and Companies, 2024-2030 The global Solid Tumors Drugs market size is poised to register 15.96% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry ... Read More
-
Biologic Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Blood and Blood Products, Allergenic Extracts, Human Cells and Tissues, Gene Therapies, Proteins, Cellular Therapies, Xenotransplantation Products), By Application (Rheumatoid Arthritis, Anemia, Cancer, Diabetes, Others), By Source (Humans, Avian Cell Culture, Yeast, Bacteria, Insects Cell Culture, Transgenics), by Region, Country, Segment, and Companies, 2024-2030
... Others), By Source (Humans, Avian Cell Culture, Yeast, Bacteria, Insects Cell Culture, Transgenics), by Region, Country, Segment, and Companies, 2024-2030 The global Biologic Therapeutics market size is poised to register 7.8% growth (CAGR) from 2024 ... Read More
-
Gene Therapy for Inherited Genetic Disorders Market Size, Trends, Analysis, and Outlook By Type (Eye Disorders, Hematological Disorders, Central Nervous System Disorders, Muscular Disorders, Others), By Application (Hospital, Clinic, Research Institute, Others), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Gene Therapy for Inherited Genetic Disorders market size is poised to register 7.62% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. ... Read More
-
Gene Therapy for CNS Disorders Market Size, Trends, Analysis, and Outlook By Indication (Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, Batten Disease), By Type (Ex Vivo, In Vivo), By End-User (Hospitals, Speciality Clinics), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Gene Therapy for CNS Disorders market size is poised to register 25.24% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Hemophilia Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Hemophilia A, Hemophilia B, Hemophilia C), By Product (Recombinant coagulation factor concentrates therapy, Plasma derived coagulation factor concentrates therapy, Non-factor replacement therapy, Others), By Therapy (Replacement Therapy, Gene Therapy, Others), by Region, Country, Segment, and Companies, 2024-2030
... (Replacement Therapy, Gene Therapy, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Hemophilia Therapeutics market size is poised to register 7.38% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
Global Gene Therapy for Inherited Genetic Disorders Market Growth (Status and Outlook) 2024-2030
... million in 2023. With growing demand in downstream market, the Gene Therapy for Inherited Genetic Disorders is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. ... Read More
-
Gene Therapy Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Vectors (Non-Viral Vectors and Viral Vectors), Indication (Neurological Diseases, Cancer, Duchenne Muscular Dystrophy, Hepatological Diseases, and Other Indications), Delivery Mode (In-Vivo and Ex-Vivo), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Diseases, and Other Indications), Delivery Mode (In-Vivo and Ex-Vivo), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) The gene therapy market size is expected to grow from ... Read More
-
Regenerative Medicine Market Size, Share, Forecast, & Trends Analysis by Product (Gene Therapy, Stem Cell, Tissue Engineering) Application (Musculoskeletal, Cancer, Cardiovascular, Immunology, Dermatology, Ophthalmology) End User - Global Forecast to 2031
... Share, Forecast, & Trends Analysis by Product (Gene Therapy, Stem Cell, Tissue Engineering) Application (Musculoskeletal, Cancer, Cardiovascular, Immunology, Dermatology, Ophthalmology) End User—Global Forecast to 2031 The global regenerative medicine market is projected to reach $37.27 ... Read More
-
Beta Thalassemia Market Assessment, By Type [Beta Thalassemia Minor, Beta Thalassemia Intermedia, Beta Thalassemia Major], By Therapy [Blood Transfusions, Iron Chelation Therapy, Folic Acid Supplements, Gene Therapy, Bone Marrow Transplants], By Distribution Channel [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies], By Region, Opportunities and Forecast, 2017-2031F
... Retail Pharmacies, Online Pharmacies], By Region, Opportunities and Forecast, 2017-2031F Global beta thalassemia market is projected to witness a CAGR of 7.75% during the forecast period 2024-2031F, growing from USD 503 million in 2023, to ... Read More
Research Assistance
